Search

Your search keyword '"Aubol BE"' showing total 248 results

Search Constraints

Start Over You searched for: Author "Aubol BE" Remove constraint Author: "Aubol BE"
248 results on '"Aubol BE"'

Search Results

2. Matrix Rigidity Controls Epithelial-Mesenchymal Plasticity and Tumor Metastasis via a Mechanoresponsive EPHA2/LYN Complex

3. Initiation of Parental Genome Reprogramming in Fertilized Oocyte by Splicing Kinase SRPK1-Catalyzed Protamine Phosphorylation

4. Disordered protein interactions for an ordered cellular transition: Cdc2-like kinase 1 is transported to the nucleus via its Ser–Arg protein substrate

6. Molecular interactions connecting the function of the serine-arginine–rich protein SRSF1 to protein phosphatase 1

7. Mobilization of a splicing factor through a nuclear kinase-kinase complex.

8. Redirecting SR Protein Nuclear Trafficking through an Allosteric Platform

9. Minimum Sampling Frequency for Accurate and Reliable Tibial Acceleration Measurements During Rearfoot Strike Running in the Field.

11. Release of SR Proteins from CLK1 by SRPK1: A Symbiotic Kinase System for Phosphorylation Control of Pre-mRNA Splicing

12. Directional Phosphorylation and Nuclear Transport of the Splicing Factor SRSF1 Is Regulated by an RNA Recognition Motif

13. Nuclear protein kinase CLK1 uses a non-traditional docking mechanism to select physiological substrates.

14. Intra-domain Cross-talk Regulates Serine-arginine Protein Kinase 1-dependent Phosphorylation and Splicing Function of Transformer 2β1*

15. N-terminus of the protein kinase CLK1 induces SR protein hyperphosphorylation.

16. Minimum Sampling Frequency for Accurate and Reliable Tibial Acceleration Measurements During Rearfoot Strike Running in the Field

24. Supplementary Figure 1 from SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo

25. Supplementary Tables 1-3, Figures 1-4 from SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo

26. Supplementary Tables 1-3, Figures 1-4 from SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo

27. Supplementary Figure 1 from SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo

28. Data from SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo

33. SRPK1 regulates RNA binding in a pre-spliceosomal complex using a catalytic bypass mechanism

34. Tibial Acceleration Reliability and Minimal Detectable Difference During Overground and Treadmill Running

35. Tibial Acceleration Reliability and Minimal Detectable Difference During Overground and Treadmill Running.

36. Disordered protein interactions for an ordered cellular transition: Cdc2-like kinase 1 is transported to the nucleus via its Ser–Arg protein substrate

37. CLK1 reorganizes the splicing factor U1-70K for early spliceosomal protein assembly

40. Matrix Rigidity Controls Epithelial-Mesenchymal Plasticity and Tumor Metastasis via a Mechanoresponsive EPHA2/LYN Complex

41. Mechanistic insights into Sky1p, a yeast homologue of the mammalian SR protein kinases

45. Mobilization of a splicing factor through a nuclear kinase–kinase complex

49. Tibial Acceleration during Running Is Higher in Field Testing Than Indoor Testing

50. A conserved sequence motif bridges two protein kinases for enhanced phosphorylation and nuclear function of a splicing factor

Catalog

Books, media, physical & digital resources